Crestline Management, LP
- SEC CIK
- 0001536054
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 3
- 0 vs. Q4 2025
- Portfolio value
- $46.3M
- −$7.06M (−13.2%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNLIDenali Therapeutics Inc. | COM | 2,210,732 | $42.4M | 91.7% | −600,000−21.3% | Reduced | History |
| SANASana Biotechnology, Inc. | COM | 755,736 | $2.18M | 4.7% | −465,201−38.1% | Reduced | History |
| EGHT8X8 Inc | COM | 990,850 | $1.64M | 3.6% | +2700.0% | Added | History |